Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: Two phase 2 single-arm trials

The Lancet

Volumn 387, Issue 10032, 2016, Pages 2026-2034

  Lawson, Jeffrey H ^a,b   Glickman, Marc H ^a,c   Ilzecki, Marek ^d   Jakimowicz, Tomasz ^e   Jaroszynski, Andrzej ^d   Peden, Eric K ^g   Pilgrim, Alison J ^a   Prichard, Heather L ^a   Guziewicz, Malgorzata ^f   Przywara, Stanisław ^d   Szmidt, Jacek ^e   Turek, Jakub ^f   Witkiewicz, Wojciech ^f   Zapotoczny, Norbert ^f   Zubilewicz, Tomasz ^d   Niklason, Laura E ^h  

^a Humacyte Inc   (United States)

^b DUKE UNIVERSITY   (United States)

^c SENTARA HEART HOSPITAL   (United States)

^d MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f Department of Paediatric Anaesthesiology and Intensive Therapy   (Poland)

^g Cardiovascular Surgery   (United States)

^h YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; ANEURYSM; ARTICLE; BLEEDING; BLOOD VESSEL FISTULA; CANNULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE FAILURE; DEVICE INFECTION; DIALYSIS; END STAGE RENAL DISEASE; FALSE ANEURYSM; FEMALE; HEMATOMA; HUMAN; HUMAN ACELLULAR VESSEL; HUMAN TISSUE; IMMUNE RESPONSE; INCIDENCE; INFECTION; ISCHEMIC MONOMELIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPATHY; PATIENT SAFETY; POLAND; PRIORITY JOURNAL; STENOSIS; THROMBOSIS; UNITED STATES; VASCULAR PATENCY; VEIN ANASTOMOSIS; VESSEL; BIOENGINEERING; BLOOD VESSEL PROSTHESIS; CELL CULTURE; CLINICAL TRIAL; CYTOLOGY; DEVICES; GRAFT SURVIVAL; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROSTHESIS DESIGN; RENAL REPLACEMENT THERAPY; VASCULAR ACCESS DEVICE; VASCULAR SMOOTH MUSCLE;

BIOENGINEERING; BLOOD VESSEL PROSTHESIS; CELLS, CULTURED; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; RENAL DIALYSIS; VASCULAR ACCESS DEVICES;

EID: 84967239634     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)00557-2     Document Type: Article

References (42)

1. P Roy-Chaudhury, BS Kelly, MA Miller et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts Kidney Int 59 2001 2325 2334
2. D Schon, SW Blume, K Neibauer, CS Hollenbeak, G de Lissovoy Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers Clin J Am Soc Nephrol 2 2007 268 276
3. BS Dixon, GJ Beck, MA Vazquez et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency N Engl J Med 360 2009 2191 2201
4. ZJ Haskal, S Trerotola, B Dolmatch et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts N Engl J Med 362 2010 494 503
5. JA Akoh, N Patel Infection of hemodialysis arteriovenous grafts J Vasc Access 11 2010 155 158
6. M Harlander-Locke, JC Jimenez, PF Lawrence et al. Bovine carotid artery (artegraft) as a hemodialysis access conduit in patients who are poor candidates for native arteriovenous fistulae Vasc Endovascular Surg 48 2014 497 502
7. PT Kennealey, N Elias, M Hertl et al. A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access J Vasc Surg 53 2011 1640 1648
8. N Das, MJ Bratby, V Shrivastava et al. Results of a seven-year, single-centre experience of the long-term outcomes of bovine ureter grafts used as novel conduits for haemodialysis fistulas Cardiovasc Intervent Radiol 34 2011 958 963
9. MP Smith, JI Spark, JV Patel, DF Border, D Oswal, AJ Lewington Massive aneurysmal dilatation of a depopulated ureteric hemodialysis xenograft Hemodial Int 13 2009 3 5
10. GT Kingston, CR Darby, IS Roberts The pathology of depopulated bovine ureter xenografts utilized for vascular access in haemodialysis patients Histopathology 55 2009 154 160
11. A Hatzibaloglou, I Velissaris, D Kaitzis, D Grekas, A Avdelidou, D Kiskinis ProCol vascular bioprosthesis for vascular access: midterm results J Vasc Access 5 2004 16 18
12. S Manduz, N Katrancioglu, E Ozker, K Dogan Early thrombosis of bovine mesenteric vein grafts after infrainguinal reconstruction Int J Angiol 17 2008 37 39
13. J Schmidli, H Savolainen, G Heller et al. Bovine mesenteric vein graft (ProCol) in critical limb ischaemia with tissue loss and infection Eur J Vasc Endovasc Surg 27 2004 251 253
14. R Madden, G Lipkowitz, B Benedetto, A Kubanov, M Miller, L Bow Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation Am J Kidney Dis 40 2002 1240 1243
15. TN McAllister, M Maruszewski, SA Garrido et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study Lancet 373 2009 1440 1446
16. W Wystrychowski, TN McAllister, K Zagalski, N Dusserre, L Cierpka, N L'Heureux First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access J Vasc Surg 60 2014 1353 1357
17. LE Niklason, J Gao, WM Abbott et al. Functional arteries grown in vitro Science 284 1999 489 493
18. SLM Dahl, AP Kypson, JH Lawson et al. Readily available tissue-engineered vascular grafts Sci Transl Med 3 2011 ra9
19. M Poh, M Boyer, A Solan et al. Blood vessels engineered from human cells Lancet 365 2005 2122 2124
20. SLM Dahl, J Koh, V Prabhakar, LE Niklason Decellularized native and engineered arterial scafolds for transplantation Cell Transplant 12 2003 659 666
21. LE Niklason, WA Abbott, J Gao et al. Morphologic and mechanical characteristics of bovine engineered arteries J Vasc Surg 33 2001 628 638
22. US Food and Drug Administration CFR - Code of Federal Regulations Title 21, Part 1271: Human Cells, Tissues and Cellular and Tissue-Based Products http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271 (accessed April 24, 2016).
23. AN Sidawy, R Gray, A Besarab et al. Recommended standards of reports dealing with arteriovenous hemodialysis accesses J Vasc Surg 35 2002 603 610
24. PE Miller, D Carlton, MH Deierhoi, DT Redden, M Allon Natural history of arteriovenous grafts in hemodialysis patients Am J Kidney Dis 36 2000 68 74
25. United States Renal Data System 2015 Annual Data Report http://www.usrds.org/adr.aspx (accessed March 20, 2016).
26. CDC Dialysis Event Protocol http://www.cdc.gov/nhsn/PDFs/pscManual/8pscDialysisEventcurrent.pdf (accessed March 20, 2016).
27. T Shinoka, D Shum-Tim, PX Ma et al. Creation of viable pulmonary artery autografts through tissue engineering J Thorac Cardiovasc Surg 115 1998 536 546
28. MA Lancaster, JA Knoblich Organogenesis in a dish: modeling development and disease using organoid technologies Science 345 2014 1247125
29. AM Raya-Rivera, D Esquillano, R Fierro-Pastrana et al. Tissue-engineered autologous vaginal organs in patients: a pilot cohort study Lancet 384 2014 329 336
30. D Valenti, H Mistry, M Stephenson A novel classification system for autogenous arteriovenous fistula aneurysms in renal access patients Vasc Endovascular Surg 48 2014 491 496
31. M Fokou, A Teyang, G Ashuntantang et al. Complications of arteriovenous fistula for hemodialysis: an 8-year study Ann Vasc Surg 26 2012 680 684
32. GB Zibari, MS Rohr, MD Landreneau et al. Complications from permanent hemodialysis vascular access Surgery 104 1988 681 686
33. TS Huber, JW Carter, RL Carter, JM Seeger Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review J Vasc Surg 38 2003 1005 1011
34. HE Katzman, MH Glickman, AF Schild, RM Fujitani, JH Lawson Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft J Am Coll Surg 201 2005 223 230
35. CE Lok, JM Sontrop, G Tomlinson Cumulative patency of contemporary fistulas versus grafts (2000-2010) Clin J Am Soc Nephrol 8 2013 810 818
36. GM Nassar, MH Glickman, RB McLafferty et al. A comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients Semin Dial 27 2014 310 318
37. C Quint, Y Kondo, RJ Manson, JH Lawson, A Dardik, LE Niklason Decellularized tissue-engineered blood vessel as an arterial conduit Proc Natl Acad Sci USA 108 2011 9214 9219
38. JJ Augustine, KJ Woodside, A Padiyar, EQ Sanchez, DE Hricik, JA Schulak Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure Transplantation 94 2012 738 743
39. MG Frid, JA Brunetti, DL Burke et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage Am J Pathol 168 2006 659 669
40. S Allahverdian, AC Chehroudi, BM McManus, T Abraham, GA Francis Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis Circulation 129 2014 1551 1559
41. AF Schild, E Perez, E Gillaspie, C Seaver, J Livingstone, A Thibonnier Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases J Vasc Access 9 2008 231 235
42. CC Chang, SM Lieberman, PV Moghe Quantitative analysis of the regulation of leukocyte chemosensory migration by a vascular prosthetic biomaterial J Mater Sci Mater Med 11 2000 337 344